Navigation Links
Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
Date:9/11/2007

ST. LOUIS, Sept. 12 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) has announced its intent to invest in a site at the Wuxi-New District Park (WND) located northwest of Shanghai, China, for its new Asia-Pacific manufacturing hub. Sigma-Aldrich has executed a memorandum of understanding with the WND authorities.

The site is to be developed in three phases. Sigma-Aldrich expects to initially invest $25 million to acquire land rights and construct its first-phase that includes a large-scale, non cGMP, multi-purpose organic manufacturing facility dedicated to supporting its SAFC(R) fine chemicals business unit. Sigma-Aldrich plans to commence construction of the new plant by year-end 2007. When fully developed the site is expected to produce raw materials, key intermediates and final products in support of SAFC's Pharma, Hitech and Supply Solutions businesses through a manufacturing plant, and analytical, packaging and warehousing facilities.

Future development phases at the site will also support Sigma-Aldrich's Research Essentials and Research Specialties business units and include the extension of analytical, packaging and warehousing facilities for its research-based business.

Commenting on the investment, Sigma-Aldrich CEO Jai Nagarkatti, stated, "As part of our 2005 strategic plan, we announced our intent to increase assets in CAPLA (Canada, Asia-Pacific, Latin America) regions to support the objective of achieving 25% of total revenue in CAPLA markets by 2010. This investment represents a significant step toward achieving that goal, as it will help us accelerate sales growth in the Asia Pacific region while allowing us to better serve both our local and global customer base."

SAFC President Frank Wicks added, "The addition of our facility in China will add essential capacity to service growing demand for SAFC products. In particular, the combination of products manufactured in China and at our European and U.S. based sites i
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Hutchinson plant expansion nears completion
2. Commerce secretary Mary Burke on innovation, expansion and BIO
3. ABC Computers receives $250,000 tax credit for expansion
4. Alfalight receives $7 million in expansion funding
5. Innovative Health Strategies near Milwaukee set to profit from Medicare expansion
6. Inacom targets diversity programs as Milwaukee expansion drives growth
7. Froedtert and Medical College plan $120 million expansion
8. API Software continues expansion
9. Republican sees nothing wrong with Doyles use of executive order
10. Republicans propose sweeping changes to promote investment
11. Republicans criticize Doyles growth package

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...TEO, Calif., Nov. 6 ,... transfer of Qutenza(TM) E.U. Marketing Authorizat...ant progress in commercial readiness activities E...r Director, Marketing; and Director, Commercial Op...s director and Audit Committee chairman , U...
(Date:11/6/2009)... The agenda for Arrowhead’s 201...hich is set to take place on February 22-24, 2010 ... day conference we will highlight key issues in fo... share their experiences. , ... agenda for Arrowhead’s 2010 Personalized M...
(Date:11/5/2009)...PANY, N.J., Nov. 5 DSM Pharmaceuti...nufacturing alliance with Galenix, Saint Jean D,Il...rcial scale manufacturing partner for Galenix comm...alenix will collaborate on business development op...hnologies, based on the strength of Galenix in dru...
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...fe Sciences,announced today that Richard Evans has...sibility will be providing advisory services to co... as well as selected investment,assignments in cap...ted,drug analyst, he will also have responsibility... in the capital markets area. "Richard brings us ...
... Presentations Accepted to Meeting, CAMBRIDGE, Ma...oday announced that 23 presentations will showcase...ts antibiotic drug discovery,platform at the upcom...robial Agents and Chemotherapy (ICAAC), taking pla... Ph.D., Chief Scientific Officer of Targanta Thera...
...al Partners and Versant Ventures Lead ...DISON, Wis., Sept. 12 OpGen, Inc., today announce...ity financing. The round,was led by CHL Medical Pa...ures, with previous investor Mason Wells also part...ecome chairman of the Board of,Directors and will ...
Other Biology Technology:Senior Research Analyst Richard Evans Joins AVOS Life Sciences 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 3Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 4Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 5Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 6Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 7OpGen Announces $23.6 Million Series A Financing 2OpGen Announces $23.6 Million Series A Financing 3
(Date:11/9/2009)...s have had their hands tied because more than half...a protein called p53. As a critical anti-cancer wa...erations within cells. When cells lose p53, tumors..., These tumors might be tough, but they,re not in...rbor Laboratory (CSHL). The chink in the tumors, a...
(Date:11/9/2009)...has inspired a 3.2m, three-year research project t...f security, energy and the environment. The Univer...y QinetiQ have just signed a collaborative contrac...ing physical sciences research. , Over the next...ity of Exeter and QinetiQ will work together to de...
(Date:11/9/2009)...utritionist whose research was instrumental in add...fants and Children (WIC) food subsidy will receive...nding achievement in the field of maternal-fetal n...fessor in the Department of Community Health Scien...chool of Public Health, will receive the award to...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 1Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 2Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 3VA Awards 243 7 Million for New Hampshire Veterans Home 48212 1HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1
... the University of Wisconsin-Madison is using musi... species in the state. , "Research shows music ...g memory, emotion, attitudes, and even behavior," ...es communication at UW-Madison and environmental c...w, who directed the project, recruited a group of ...
...008 SRI International announced today that it has ...s grant from the Bill & Melinda Gates Foundation. ...h research project conducted by Krishna Kodukula, ...enter for Advanced Drug Research (CADRE) in Shenan...ociate director of Proteomics and Protein Biochemi...
...he University of Houston to use technologies with ...tools that will help doctors and technicians bette...d neck cancer. , Dr. Ali Kamrani, founding direct...ory at UH and a former auto industry researcher, i...r and deputy research director of radiation physic...
Other Biology News:SRI International receives $100,000 Grand Challenges Explorations grant 2From cars to cancer: UH professor employs auto industry tools for tumor therapy 2From cars to cancer: UH professor employs auto industry tools for tumor therapy 3From cars to cancer: UH professor employs auto industry tools for tumor therapy 4
Customized Competent E. coli. from Molecular Cloning Laboratories (MCLAB)
Fluorescent Standards Red Standard from Invitrogen
X-Gal from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Oligodendrocyte Marker O1 Monoclonal Antibody, Unconjugated, Clone O1 from R&D Systems
Biology Products: